|
Drug repurposing for treatment of congenital vascular malformations
Reference #: 1659
The University of South Carolina is offering licensing opportunities for Drug Repurposing for Treatment of Congenital Vascular Malformations.
Background:
Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation (CM), a.k.a.,...
Published: 12/3/2025
|
Updated: 5/17/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, Chao Gao, Anil Jegga, Yunguan Wang, Sudhir Ghandikota, Marcelo Hochman
Keywords(s):
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 Spike protein under obesity
Reference #: 01642
The University of South Carolina is offering licensing opportunities for Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 spike protein under obesity.
Background:
Today, the spread of Coronavirus Disease 2019 (COVID-19) continues, and while millions of patients have recovered, a significant number experience prolonged...
Published: 6/5/2026
|
Updated: 5/17/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, Taixing Cui
Keywords(s):
Category(s): Health Sciences, Biomedical and Life Sciences
|
|
Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation
Reference #: 01657
The University of South Carolina is offering licensing opportunities for Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation.
Background:
Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation...
Published: 12/3/2025
|
Updated: 4/24/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, J. Stuart Nelson
Keywords(s):
Category(s): Biomedical and Life Sciences
|
|
Targeting Treatment For ADAM30 In Pathological Cells
Reference #: 01462
The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells
Background:
The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...
Published: 7/10/2026
|
Updated: 5/7/2021
|
Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao
Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation
Category(s): Health Sciences, Biomedical and Life Sciences
|